Skip to content

Pulpotomy With CEM vs Pulpectomy With Ca(OH)2/Iodoform in Primary Molars

Clinical and Radiographic Evaluation of Pulpotomy Using Calcium-Enriched Mixture Versus Pulpectomy Using Calcium Hydroxide/Iodoform Paste for the Treatment of Primary Molars With Irreversible Pulpitis: A Randomized Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07265063
Enrollment
50
Registered
2025-12-04
Start date
2025-12-01
Completion date
2026-12-01
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carious Primary Molars

Brief summary

Will Calcium-Enriched Mixture (CEM) cement pulpotomy have less postoperative pain and more clinical and radiographic success compared to Calcium Hydroxide/Iodoform (Metapex) pulpectomy when managing second primary molars with irreversible pulpitis?

Interventions

PROCEDUREPulpotomy using Calcium-Enriched Mixture (CEM) Cement

pulpotomy procedure using (CEM) Cement as pulp dressing material

PROCEDUREPulpectomy using Calcium Hydroxide/Iodoform Paste (Metapex)

pulpectomy procdure performed using Metapex paste as root canal filling material

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

statistician

Eligibility

Sex/Gender
ALL
Age
6 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* Children: Aged 6-8 years of both sexes. Cooperative and medically free. Diagnosed with irreversible pulpitis based on clinical and radiographic criteria. Parents/legal guardians provide written informed consent. Parents able to attend follow-up visits. Teeth: Deep carious second primary molars with signs of irreversible pulpitis. No clinical signs of necrosis (abscess, fistula, mobility). No radiographic signs of necrosis (periapical lesion or resorption).

Exclusion criteria

* Children: With systemic or mental disorders. Whose parents refuse to give consent. Uncooperative behavior. Teeth: Signs of pulpal necrosis (swelling, fistula, pathological mobility). Periapical or furcal radiolucency exceeding half the furcation-apical distance. Non-restorable teeth, root caries, internal/external resorption, or calcified canals.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain Intensity1, 3, 6, 9, and 12 months post-treatmentPain intensity will be evaluated using the Visual Analog Scale (VAS) of faces, rated from 0 (no pain) to 5 (severe pain). Assessment will be performed at 1, 3, 6, 9, and 12 months after treatment. Clinical success will be considered when the patient reports no pain (score = 0).

Secondary

MeasureTime frameDescription
Evaluation of Clinical Success1, 3, 6, 9, and 12 months post-treatmentClinical success will be evaluated by the absence of pain, swelling, tenderness to percussion, sinus, fistula, and pathological mobility. Clinical assessment will be performed at 1, 3, 6, 9, and 12 months postoperatively.
Evaluation of Radiographic Success6 and 12 months post-treatmentRadiographic success will be defined as the absence of widening of the periodontal ligament space, internal/external root resorption, or radiolucency in the furcation or periapical area. Radiographic failure will be recorded if any of these findings are observed.

Contacts

Primary ContactAlaa Hassab Elrasoul Abdelmajed, Master degree
alaa.abdelmagid@dentistry.cu.edu.eg00201507339601

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026